D1: DOHH2 Baseline control

SRS9279508 SAMN19891591 GSM5400956 D1: DOHH2 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Baseline Control cell type DOHH-2 disease classification GCB-DLBCL SRS9279510 SAMN19891589 GSM5400957 D3: DOHH2 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Olaparib cell type DOHH-2 disease classification GCB-DLBCL SRS9279511 SAMN19891586 GSM5400959 D6: DOHH2 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Combo cell type DOHH-2 disease classification GCB-DLBCL SRS9279512 SAMN19891587 GSM5400958 D4: DOHH2 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment 177Lu-NNV003 cell type DOHH-2 disease classification GCB-DLBCL SRS9279513 SAMN19891593 GSM5400961 G3: Granta Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Olaparib cell type Granta-519 disease classification MCL SRS9279514 SAMN19891594 GSM5400960 G1: Granta Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Baseline Control cell type Granta-519 disease classification MCL SRS9279515 SAMN19891584 GSM5400962 G4: Granta Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment 177Lu-NNV003 cell type Granta-519 disease classification MCL SRS9279516 SAMN19891581 GSM5400964 O1: Oci-Ly-10 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Baseline Control cell type Oci-Ly-10 disease classification ABC-DLBCL SRS9279517 SAMN19891583 GSM5400963 G6: Granta Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Combo cell type Granta-519 disease classification MCL SRS9279518 SAMN19891579 GSM5400965 O3: Oci-Ly-10 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Olaparib cell type Oci-Ly-10 disease classification ABC-DLBCL SRS9279519 SAMN19891578 GSM5400966 O4: Oci-Ly-10 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment 177Lu-NNV003 cell type Oci-Ly-10 disease classification ABC-DLBCL SRS9279520 SAMN19891574 GSM5400968 R1: Rec-1 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Baseline Control cell type Rec-1 disease classification MCL SRS9279521 SAMN19891575 GSM5400967 O6: Oci-Ly-10 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Combo cell type Oci-Ly-10 disease classification ABC-DLBCL SRS9279522 SAMN19891572 GSM5400969 R3: Rec-1 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Olaparib cell type Rec-1 disease classification MCL SRS9279523 SAMN19891570 GSM5400970 R4: Rec-1 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment 177Lu-NNV003 cell type Rec-1 disease classification MCL SRS9279524 SAMN19891568 GSM5400971 R6: Rec-1 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name MCL cell line treatment Combo cell type Rec-1 disease classification MCL SRS9279525 SAMN19891566 GSM5400972 S1: SUDHL-4 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Baseline Control cell type SU-DHL-4 disease classification GCB-DLBCL SRS9279526 SAMN19891565 GSM5400973 S3: SUDHL-4 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Olaparib cell type SU-DHL-4 disease classification GCB-DLBCL SRS9279527 SAMN19891563 GSM5400975 S6: SUDHL-4 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Combo cell type SU-DHL-4 disease classification GCB-DLBCL SRS9279528 SAMN19891564 GSM5400974 S4: SUDHL-4 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment 177Lu-NNV003 cell type SU-DHL-4 disease classification GCB-DLBCL SRS9279529 SAMN19891562 GSM5400976 U1: U2932 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Baseline Control cell type U-2932 disease classification ABC-DLBCL SRS9279530 SAMN19891560 GSM5400978 U4: U2932 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment 177Lu-NNV003 cell type U-2932 disease classification ABC-DLBCL SRS9279531 SAMN19891561 GSM5400977 U3: U2932 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Olaparib cell type U-2932 disease classification ABC-DLBCL SRS9279532 SAMN19891559 GSM5400979 U6: U2932 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name ABC-DLBCL cell line treatment Combo cell type U-2932 disease classification ABC-DLBCL SRS9279533 SAMN19891557 GSM5400981 W3: WSU-DLCL-2 Drug 2: Olaparib 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Olaparib cell type WSU-DLCL-2 disease classification GCB-DLBCL SRS9279534 SAMN19891558 GSM5400980 W1: WSU-DLCL-2 Baseline control 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Baseline Control cell type WSU-DLCL-2 disease classification GCB-DLBCL SRS9279535 SAMN19891556 GSM5400982 W4: WSU-DLCL-2 Drug 3: 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment 177Lu-NNV003 cell type WSU-DLCL-2 disease classification GCB-DLBCL SRS9279536 SAMN19891555 GSM5400983 W6: WSU-DLCL-2 Drugs (2+3): Olaparib + 177Lu-NNV003 9606 Homo sapiens bioproject 741501 PRJNA741501 source_name GCB-DLBCL cell line treatment Combo cell type WSU-DLCL-2 disease classification GCB-DLBCL